By Rédaction Africa Links 24 with Lizzy Lawrence
Published on 2024-01-18 14:41:51
Apple has made the decision to remove the blood oxygen measurement feature from its Apple Watches in response to an import ban issued by the International Trade Commission. This ban came after a dispute with medical device company Masimo, which claimed that the blood oxygen feature on the Apple Watch was too similar to its own technology.
The ban, which officially went into effect on Christmas, was temporarily halted by a U.S. appeals court, but was later lifted, forcing Apple to halt sales of the Apple Watch. Instead of pulling the watches from the market, Apple has opted to remove the blood oxygen feature and will begin selling modified watches that do not include this feature.
However, Apple has stated that already-purchased Apple Watches will still have the blood oxygen feature. The company is continuing to appeal the ITC ban, but this decision to remove the blood oxygen feature is a setback in Apple’s mission to establish its watch as a necessary public health tool.
The dispute between Apple and Masimo has led to a back and forth battle over the blood oxygen feature on the Apple Watch. This decision to remove the feature is the latest development in this ongoing saga.
Despite this setback, Apple is determined to continue its appeal of the ITC ban and remains committed to developing the Apple Watch as a valuable public health tool. This decision will have implications for the future of the Apple Watch and its capabilities as a health monitoring device.
Read the original article on Africa Health News
